Moody Aldrich Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.25M | Sell |
|
|||||
|
2025
Q2 | $6.41M | Sell |
|
|||||
|
2025
Q1 | $7.27M | Buy |
|
|||||
|
2024
Q4 | $3.82M | Sell |
|
|||||
|
2024
Q3 | $5.45M | Sell |
|
|||||
|
2024
Q2 | $4.97M | Sell |
|
|||||
|
2024
Q1 | $5.24M | Sell |
|
|||||
|
2023
Q4 | $5.32M | Sell |
|
|||||
|
2023
Q3 | $5.15M | Buy |
|
|||||
|
2023
Q2 | $4.65M | Buy |
|
|||||
|
2023
Q1 | $2.01M | Sell |
|
|||||
|
2022
Q4 | $4.02M | Sell |
|
|||||
|
2022
Q3 | $5.46M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.62M | Sell |
|
|||||
|
2021
Q3 | $1.68M | Buy |
|
|||||
|
2021
Q2 | $2.97M | Sell |
|
|||||
|
2021
Q1 | $2.52M | Buy |
|
|||||
|
2020
Q4 | $3.55M | Sell |
|
|||||
|
2020
Q3 | $3.11M | Buy |
|
|||||
|
2020
Q2 | $2.48M | Sell |
|
|||||
|
2020
Q1 | $3.66M | Buy |
|
|||||
|
2019
Q4 | $6.43M | Sell |
|
|||||
|
2019
Q3 | $1.48M | Buy |
|
|||||
|
2019
Q2 | $1.84M | Buy |
|